Ali Salahpour
Affiliations: | Pharmacology and Toxicology | University of Toronto, Toronto, ON, Canada |
Website:
http://www.pharmtox.utoronto.ca/faculty/directory/salapour.htmGoogle:
"Ali Salahpour"Bio:
http://www.pharmtox.utoronto.ca/Assets/Pharmtox+Digital+Assets/Graduate/Almanacs/July-August-2009.pdf
Mean distance: 16.3 (cluster 11) | S | N | B | C | P |
Cross-listing: Chemistry Tree
Parents
Sign in to add mentorMichel Bouvier | grad student | 1996-2002 | Université de Montréal | |
(Etude de la dimerisaton du recepteur beta2-adrenergique.) | ||||
Marc Caron | post-doc | 2002-2009 | Duke |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Mielnik CA, Sugamori KS, Finlay DB, et al. (2020) A novel allosteric modulator of the cannabinoid CB receptor ameliorates hyperdopaminergia endophenotypes in rodent models. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology |
Mielnik CA, Binko MA, Chen Y, et al. (2020) Consequences of NMDA receptor deficiency can be rescued in the adult brain. Molecular Psychiatry |
Intson K, van Eede MC, Islam R, et al. (2019) Progressive neuroanatomical changes caused by Grin1 loss-of-function mutation. Neurobiology of Disease. 104527 |
Chen Y, Milenkovic M, Horsfall W, et al. (2018) Restoring striatal WAVE-1 improves maze exploration performance of GluN1 knockdown mice. Plos One. 13: e0199341 |
Lam VM, Mielnik CA, Baimel C, et al. (2018) Behavioral Effects of a Potential Novel TAAR1 Antagonist. Frontiers in Pharmacology. 9: 953 |
Islam R, Trépanier MO, Milenkovic M, et al. (2017) Vulnerability to omega-3 deprivation in a mouse model of NMDA receptor hypofunction. Npj Schizophrenia. 3: 12 |
Beerepoot P, Nazari R, Salahpour A. (2016) Pharmacological chaperone approaches for rescuing GPCR mutants: Current state, challenges, and screening strategies. Pharmacological Research |
Beerepoot P, Lam VM, Salahpour A. (2016) Pharmacological Chaperones of the Dopamine Transporter Rescue Dopamine Transporter Deficiency Syndrome Mutations in Heterologous Cells. The Journal of Biological Chemistry |
Lohr KM, Masoud ST, Salahpour A, et al. (2016) Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease. The European Journal of Neuroscience |
Lam VM, Espinoza S, Gerasimov AS, et al. (2015) In-vivo pharmacology of Trace-Amine Associated Receptor 1. European Journal of Pharmacology |